Clinical Trials Browser

Recruiting × lenvatinib × Thoracic × Clear all

NCT04938817 2026-03-19

KEYNOTE-B98

Phase 1/2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT04300556 2026-03-13

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Phase 1/2 Recruiting

BreastGynecologicThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05024214 2025-05-29

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Phase 1/2 Recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular

NCT06318286 2025-05-25

PENINSULA

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT05384015 2025-04-10

PEERS

Phase 2 Recruiting

Lung Neoplasms

NCT04951947 2024-09-19

JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT05832827 2023-10-23

Artemis

Phase 2 Recruiting

Thymoma

NCT04875585 2022-08-24

INNWOP1

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung